I don't disagree with your points. And I'd ad
Post# of 148168
And I'd add that with a molecule that has as much promise as leronlimab, where are the Baker Brothers, the Perceptives, and all of the other biotech-focused hedge funds that don't care if a company is listed on OTC?
I can wait for leronlimab to capture its first approval, as I am certain that the institutional flood gates will open ... not to mention BP having to face the reality that the horses have left the barn.